Literature DB >> 26497969

The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy.

Qi Tang1, Gengyan Xiong1, Xuesong Li2, Dong Fang1, Chenguang Xi1, Lei Zhang1, Kaiwei Yang1, Lin Yao1, Cuijian Zhang1, Wei Yu1, Qun He1, Kan Gong1, Zhisong He1, Liqun Zhou3.   

Abstract

PURPOSE: To evaluate the association between tumor squamous and/or glandular differentiation and tumor biological characteristics and to validate the impact of these histologic variants on oncologic outcomes of UTUC patients.
METHODS: We retrospectively analyzed the data of 687 UTUC patients who underwent radical nephroureterectomy in our institute, from Aug 1, 1999, to Dec 31, 2011. All pathologic sections were reevaluated for histologic differentiation variations (squamous and glandular). The clinicopathological variables of patients were reviewed.
RESULTS: Among the 687 UTUC patients in our study, 53 (7.7 %) had squamous differentiation, 20 (2.9 %) had glandular differentiation and 8 (1.2 %) had both histologic variants. Patients with mixed histologic variant tended to have significant larger percentage of sessile tumor architecture (58.0 vs 18.2 %), presence of CIS (7.4 vs 2.3 %), advanced T stage, advanced tumor grade and lymph node metastasis (17.3 vs 6.6 %; all p < 0.05). Patients with squamous and/or glandular differentiation had significant worse cancer-specific survival than pure UTUC patients (p < 0.001), while significant difference of recurrence-free survival between two groups was not observed (p = 0.126). Patients with both squamous and glandular differentiation did not show significantly worse CSS than those with single histologic variant. Univariate analyses revealed that tumor squamous and/or glandular differentiation was a significant factor on survival (p < 0.001). However, the influence did not remain significant after adjusted for other factors in the multivariate analyses (p = 0.076, HR 1.42).
CONCLUSIONS: UTUC patients with squamous and/or glandular differentiation are more likely to have aggressive tumor biological features and tend to have worse postoperative outcomes.

Entities:  

Keywords:  Histologic differentiation; Prognosis; Upper tract urothelial carcinoma

Mesh:

Year:  2015        PMID: 26497969     DOI: 10.1007/s00345-015-1715-0

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  26 in total

Review 1.  Variant forms of bladder cancer: basic considerations on treatment approaches.

Authors:  Francesc Pons; Anna Orsola; Juan Morote; Joaquim Bellmunt
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

2.  The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.

Authors:  Simon P Kim; Igor Frank; John C Cheville; R Houston Thompson; Christopher J Weight; Prabin Thapa; Stephen A Boorjian
Journal:  J Urol       Date:  2012-06-14       Impact factor: 7.450

3.  Urothelial malignancy in nephropathy due to Chinese herbs.

Authors:  J P Cosyns; M Jadoul; J P Squifflet; P J Van Cangh; C van Ypersele de Strihou
Journal:  Lancet       Date:  1994-07-16       Impact factor: 79.321

4.  European guidelines on upper tract urothelial carcinomas: 2013 update.

Authors:  Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat
Journal:  Eur Urol       Date:  2013-03-19       Impact factor: 20.096

5.  Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.

Authors:  Giovanni Lughezzani; Maxine Sun; Claudio Jeldres; Ahmed Alasker; Lars Budäus; Shahrokh F Shariat; Mathieu Latour; Hugues Widmer; Alain Duclos; Martine Jolivet-Tremblay; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Urology       Date:  2010-02       Impact factor: 2.649

6.  Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).

Authors:  Emil Scosyrev; Benjamin W Ely; Edward M Messing; V O Speights; H Barton Grossman; David P Wood; Ralph W de Vere White; Nicholas J Vogelzang; Donald L Trump; Ronald B Natale; Catherine M Tangen; E David Crawford; Ian M Thompson
Journal:  BJU Int       Date:  2010-11-24       Impact factor: 5.588

7.  Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.

Authors:  Sten Holmäng; Subodh M Lele; Sonny L Johansson
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

8.  Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.

Authors:  Richard Zigeuner; Shahrokh F Shariat; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Alon Weizer; Eiji Kikuchi; Mesut Remzi; Jay D Raman; Christian Bolenz; Karim Bensalah; Umberto Capitanio; Theresa M Koppie; Wassim Kassouf; Kanishka Sircar; Jean-Jacques Patard; Mario I Fernández; Christopher G Wood; Francesco Montorsi; Philipp Ströbel; Jeffery C Wheat; Andrea Haitel; Mototsugu Oya; Charles C Guo; Casey Ng; Daher C Chade; Arthur Sagalowsky; Cord Langner
Journal:  Eur Urol       Date:  2009-11-25       Impact factor: 20.096

9.  Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

Authors:  C J Logothetis; D E Johnson; C Chong; F H Dexeus; A Sella; S Ogden; T Smith; D A Swanson; R J Babaian; K I Wishnow
Journal:  J Clin Oncol       Date:  1988-10       Impact factor: 44.544

Review 10.  The impact of variant histology on the outcome of bladder cancer treated with curative intent.

Authors:  Peter C Black; Gordon A Brown; Colin P N Dinney
Journal:  Urol Oncol       Date:  2008-01-14       Impact factor: 3.498

View more
  11 in total

Review 1.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

2.  Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation.

Authors:  Tao Wang; Zheng Lv; Huayi Feng; Jinlong Li; Bo Cui; Yang Yang; Xing Huang; Xiangyi Zhang; Xintao Li; Xin Ma
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

3.  Upper Urinary Tract Urothelial Carcinoma With Squamous, Glandular, and Sarcomatoid Variants in a Horseshoe Kidney: A Novel Case Report and Literature Review.

Authors:  Jehad Fikri; Abdullah M Almalki; Sattam A Almalki; Muradi Murad; Sara Makhdoum; Fadil Hassan
Journal:  Cureus       Date:  2021-11-16

Review 4.  Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature.

Authors:  Aurélie Mbeutcha; Romain Mathieu; Morgan Rouprêt; Kilian M Gust; Alberto Briganti; Pierre I Karakiewicz; Shahrokh F Shariat
Journal:  Transl Androl Urol       Date:  2016-10

5.  The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy.

Authors:  Xiaohong Su; Dong Fang; Xuesong Li; Gengyan Xiong; Lei Zhang; Han Hao; Yanqing Gong; Zheng Zhang; Liqun Zhou
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

6.  Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.

Authors:  Gang Li; Jianpeng Yu; Hualin Song; Shimiao Zhu; Libin Sun; Zhiqun Shang; Yuanjie Niu
Journal:  BMC Cancer       Date:  2017-08-08       Impact factor: 4.430

7.  Glandular differentiation in pT1 urothelial carcinoma of bladder predicts poor prognosis.

Authors:  Guobin Zhao; Chao Wang; Yuhong Tang; Xin Liu; Zihao Liu; Gang Li; Yanhui Mei
Journal:  Sci Rep       Date:  2019-03-29       Impact factor: 4.379

Review 8.  Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Gopal Sharma; Anuj Kumar Yadav; Tarun Pareek; Pawan Kaundal; Shantanu Tyagi; Sudheer Kumar Devana; Shrawan Kumar Singh
Journal:  Int Braz J Urol       Date:  2022 May-Jun       Impact factor: 3.050

9.  Differentiation of Urothelial Carcinoma into Two Distinct Subtypes, Glandular and Squamous, in Three Different Organs.

Authors:  Jose M El-Asmar; Moustafa Moussally; Nassib Abou Heidar; Wassim Wazzan; Jad A Degheili
Journal:  Cureus       Date:  2020-03-15

10.  The prognostic value of tumor architecture in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: A systematic review and meta-analysis.

Authors:  Hu Zhao; Lijin Zhang; Bin Wu; Zhenlei Zha; Jun Yuan; Yuefang Jiang; Yejun Feng
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.